Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV

AIDS

Volumn 20, Issue 3, 2006, Pages 419-427

  Lacombe, Karine ^a,e   Massari, Véronique ^a   Girard, Pierre Marie ^a   Serfaty, Lawrence ^a   Gozlan, Joël ^a   Pialoux, Gilles ^b   Mialhes, Patrick ^d   Molina, Jean Michel ^c   Lascoux Combe, Caroline ^c   Wendum, Dominique ^a   Carrat, Fabrice ^a   Zoulim, Fabien ^d  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL TENON   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔTEL DIEU   (France)

^e INSERM   (France)

Author keywords

Antiretrovirals; Chronic hepatitis B; Hepatitis B genotype; HIV; Liver fibrosis

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; HEPATITIS B SURFACE ANTIGEN; HEPATITIS E ANTIGEN; LAMIVUDINE; PROTEINASE INHIBITOR; RECOMBINANT INTERFERON; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SERODIAGNOSIS; SUPERINFECTION; VIRAL GENETICS; VIRUS GENOME; VIRUS REPLICATION; VIRUS VIRULENCE; WESTERN BLOTTING;

ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENOME, VIRAL; GENOTYPE; HEPATITIS B, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; LIVER CIRRHOSIS; MALE;

EID: 33645035027     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000200537.86984.0e     Document Type: Article

References (30)

1. Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, McNally T, Kelly CE, Tedder RS, Weller IV. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997; 11:597-606.
2. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, for the EuroSIDA Group. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active anti-retroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19:593-601.
3. Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, for the EuroSIDA Group. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA Study. AIDS 2002; 16:1663-1671.
4. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, for the Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360:1921-1926.
5. de Torres M, Poynard T. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol 2003; 2:5-11.
6. Martin-Carbonero L, Benhamou Y, Puoti M, Berenguer J, Mallolas J, Quereda C, et al. Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. Clin Infect Dis 2004; 38:128-133.
7. Grandjacques C, Pradat P, Stuyver L, Chevallier M, Chevallier P, Pichoud C, et al. Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol 2000; 33:430-439.
8. Fung SK, Lok AS. Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 2004; 40:790-792.
9. Yuen MF, Sablon E, Yuan HJ, Wong DK, Hui CK, Wong BC, et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology 2003; 37:562-567.
10. Jardi R, Rodriguez F, Buti M, Costa X, Valdes A, Allende H, et al. Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers. J Hepatol 2004; 40:507-514.
11. Bernillon P, Lievre L, Pillonel J, Laporte A, Costagliola D. Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993. The Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodeficience Humaine. Int J Epidemiol 2000; 29:168-174.
12. Wilson JW, Bean P, Robins T, Graziano F, Persing DH. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay. J Clin Microbiol 2000; 38:3022-3028.
13. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. the METAVIR Cooperative Study Group. Hepatology 1996; 24:289-293.
14. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44:1049-1060.
15. Stuyver L, de Gendt S, van Geyt C, Zoulim F, Fried M, Schinazi RF, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000; 81:67-74.
16. Koibuchi T, Hitani A, Nakamura T, Nojiri N, Nakajima K, Jyuji T, et al. Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan. J Med Virol 2001; 64:435-440.
17. Kato H, Orito E, Gish RG, Sugauchi F, Suzuki S, Ueda R, et al. Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F). J Virol 2002; 76:6131-6137.
18. Chu CJ, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002; 122:1756-1762.
19. Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003; 37:19-26.
20. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001; 34:590-594.
21. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000; 33:998-1002.
22. Rodriguez-Frias F, Buti M, Jardi R, Cotrina M, Viladomiu L, Esteban R, et al. Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations. Hepatology 1995; 22:1641-1647.
23. Powderly WG. Antiretroviral therapy in patients with hepatitis and HIV: weighing risks and benefits. Clin Infect Dis 2004; 38(Suppl 2):S109-S113.
24. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2001; 34:617-624.
25. Hannoun C, Krogsgaard K, Horal P, Lindh M, for the Interpred Trial Group. Genotype mixtures of hepatitis B virus in patients treated with interferon. J Infect Dis 2002; 186:752-759.
26. Perez-Olmeda M, Nunez M, Garcia-Samaniego J, Rios P, Gonzalez-Lahoz J, Soriano VS. Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications. AIDS Res Hum Retroviruses 2003; 19:657-659.
27. Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, et al. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 2004; 190:400-408.
28. Dieterich DT, Robinson PA, Love J, Stern JO. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis 2004; 38 (Suppl 2):S80-S89.
29. Macias J, Castellano V, Merchante N, Palacios RB, Mira JA, Saez C, et al. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine. AIDS 2004; 18:767-774.
30. de Torres M, Poynard T. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol 2003; 2:5-11.